Kyle Jablonski’s work focuses on utility and design patent prosecution in the United States and abroad. Kyle specializes in patent prosecution within the health sphere, including medical devices, diagnostic equipment, and clinical methodology. Kyle also has experience with patents related to autonomous vehicles and image processing.
Kyle joined BCIP in 2023 after graduating from Rutgers Law School, where he was recognized for his scholastic achievement in Health and Intellectual Property Law. He was an active member of the Rutgers Intellectual Property Law Clinic, where he successfully aided prosecution of multiple trademark matters. Prior to law school, Kyle worked extensively in immunology research at The Ohio State University and received additional training in Medical Laboratory Science (MLS). His work focused on mechanisms of inflammation and autoimmunity, particularly in Multiple Sclerosis (MS), Systemic Lupus Erythematosus (SLE), and Rheumatoid Arthritis (RA). Kyle has published several immunology-focused articles in peer-reviewed journals. He also has presented his research at both national and international conferences.
Kyle enjoys a variety of outdoor pursuits, including golf, snowboarding, and hiking. He is an avid fan of Cleveland and Ohio sports.
J.D., Rutgers University School of Law, 2023
M.S., Allied Health, The Ohio State University, 2017
B.S., Microbiology, The Ohio State University, 2014, with Research Distinction
B.S., Pharmaceutical Science, The Ohio State University, 2013
New Jersey (2023)
Jablonski, K.A., et al., Physical activity prevents acute inflammation in a gout model by downregulation of TLR2 on circulating neutrophils as well as inhibition of serum CXCL1 and is associated with decreased pain and inflammation in gout patients. (2020) PLOS ONE.
Jablonski, K.A., et al., Control of the Inflammatory Macrophage Transcriptional Signature by miR-155. (2016) PLOS ONE.
Jablonski, K.A., et al., Novel Markers to Delineate Murine M1 and M2 Macrophages. (2015) PLOS ONE.